GleamWall
中文EN

RMD RESMED INC

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 943819 · Fiscal year ends 06/30

Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.0%
TTM net income YoY10.8%
TTM EPS YoY12.4%
Revenue 3-yr CAGR9.4%
Net income 3-yr CAGR20.7%

Margins

Gross margin61.1%
Operating margin33.0%
Net margin27.8%
FCF margin28.1%
EBITDA margin36.4%

Returns

ROE26.4%
ROA19.3%
ROIC (approx.)27.9%
Asset turnover0.69x

Leverage & solvency

Liabilities / assets27.6%
Debt / equity0.07x
Current ratio2.65x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.11x
Accruals ratio-2.2%
Payout ratio22.4%
Capex / revenue2.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-06-30FY20252025-06-30
Income statement
Revenue$5.65B$5.15B
Cost of revenue$2.20B$2.09B
Gross profit$3.45B$3.05B
R&D expense$378.29M$331.28M
SG&A expense$1.12B$993.05M
Operating income$1.89B$1.69B
Pretax income$1.92B$1.68B
Income tax$396.12M$276.84M
Net income$1.52B$1.40B
EBITDA$2.09B$1.88B
EPS (basic)10.479.55
EPS (diluted)10.439.51
Dividends declared per share2.402.12
Weighted avg. shares (diluted)146.05M147.34M
Balance sheet
Cash & equivalents$1.47B$1.21B
Receivables$1.04B$939.49M
Inventory$945.80M$927.71M
Current assets$4.32B$3.51B
PP&E, net$581.83M$550.79M
Goodwill$2.91B$3.05B
Intangibles$452.74M$464.86M
Total assets$8.97B$8.17B
Current liabilities$1.40B$1.02B
Short-term debt$259.95M$9.90M
Long-term debt$399.42M$658.39M
Total debt$659.37M$668.29M
Total liabilities$2.38B$2.21B
Shareholders' equity$6.59B$5.97B
Net debt-$809.87M-$541.16M
Shares outstanding144.24M146.39M
Cash flow statement
Operating cash flow$1.81B$1.75B
Capital expenditure$156.28M$89.86M
Free cash flow$1.65B$1.66B
Investing cash flow-$545.20M-$200.04M
Financing cash flow-$1.01B-$606.25M
Depreciation & amortization$201.34M$198.47M
Stock-based compensation$104.35M$91.66M
Dividends paid$349.66M$310.88M
Share buybacks$700.04M$300.02M

Free plan shows the latest 2 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.